SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-008603
Filing Date
2022-04-08
Accepted
2022-04-08 16:32:44
Documents
15
Period of Report
2022-04-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20220407_8k.htm   iXBRL 8-K 21675
2 EXHIBIT 99.1 ex_356384.htm EX-99.1 14913
7 image01.jpg GRAPHIC 14635
  Complete submission text file 0001437749-22-008603.txt   217710

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20220408.xsd EX-101.SCH 3600
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20220408_def.xml EX-101.DEF 11918
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20220408_lab.xml EX-101.LAB 15965
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20220408_pre.xml EX-101.PRE 12129
9 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20220407_8k_htm.xml XML 2676
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 22817484
SIC: 2834 Pharmaceutical Preparations